Review
. 2019 Jan;50(2).
doi: 10.1002/jmri.26654.

Contrast-enhanced MRI for breast cancer screening

Ritse M Mann 1 Christiane K Kuhl 2 Linda Moy 3 
Affiliations
  • PMID: 30659696
  •     118 References
  •     17 citations

Abstract

Multiple studies in the first decade of the 21st century have established contrast-enhanced breast MRI as a screening modality for women with a hereditary or familial increased risk for the development of breast cancer. In recent studies, in women with various risk profiles, the sensitivity ranges between 81% and 100%, which is approximately twice as high as the sensitivity of mammography. The specificity increases in follow-up rounds to around 97%, with positive predictive values for biopsy in the same range as for mammography. MRI preferentially detects the more aggressive/invasive types of breast cancer, but has a higher sensitivity than mammography for any type of cancer. This performance implies that in women screened with breast MRI, all other examinations must be regarded as supplemental. Mammography may yield ~5% additional cancers, mostly ductal carcinoma in situ, while slightly decreasing specificity and increasing the costs. Ultrasound has no supplemental value when MRI is used. Evidence is mounting that in other groups of women the performance of MRI is likewise superior to more conventional screening techniques. Particularly in women with a personal history of breast cancer, the gain seems to be high, but also in women with a biopsy history of lobular carcinoma in situ and even women at average risk, similar results are reported. Initial outcome studies show that breast MRI detects cancer earlier, which induces a stage-shift increasing the survival benefit of screening. Cost-effectiveness is still an issue, particularly for women at lower risk. Since costs of the MRI scan itself are a driving factor, efforts to reduce these costs are essential. The use of abbreviated MRI protocols may enable more widespread use of breast MRI for screening. Level of Evidence: 1 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019;50:377-390.

Keywords: MRI; breast cancer; mammography; screening.

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, +3 authors, Heribert B Bieling.
J Clin Oncol, 2014 Jun 25; 32(22). PMID: 24958821
Highly Cited.
Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.
Katja Pinker, Linda Moy, +8 authors, Thomas H Helbich.
Invest Radiol, 2018 Apr 06; 53(10). PMID: 29620604    Free PMC article.
Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, +27 authors, Olufunmilayo I Olopade.
Clin Cancer Res, 2018 Aug 30; 25(6). PMID: 30154229    Free PMC article.
Abbreviated breast MRI for screening women with dense breast: the EA1141 trial.
Christiane K Kuhl.
Br J Radiol, 2017 Jul 28; 91(1090). PMID: 28749202    Free PMC article.
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, +7 authors, Pål Møller.
Breast, 2007 Feb 24; 16(4). PMID: 17317184
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, +15 authors, MARIBS study group.
Lancet, 2005 May 25; 365(9473). PMID: 15910949
Highly Cited.
Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Janice S Sung, Sarah Stamler, +6 authors, Christopher E Comstock.
Radiology, 2016 Apr 21; 280(3). PMID: 27097237    Free PMC article.
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Sepideh Saadatmand, Inge-Marie Obdeijn, +9 authors, Madeleine M Tilanus-Linthorst.
Int J Cancer, 2015 Mar 31; 137(7). PMID: 25820931
Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ.
Theresa Schwartz, Amy Cyr, Julie Margenthaler.
J Surg Res, 2014 Oct 04; 193(2). PMID: 25277350
Abbreviated MRI of the Breast: Does It Provide Value?
Doris Leithner, Linda Moy, +3 authors, Katja Pinker.
J Magn Reson Imaging, 2018 Sep 09; 49(7). PMID: 30194749    Free PMC article.
Review.
Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.
Fiona J Gilbert, Ruth M L Warren, +5 authors, United Kingdom Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.
Radiology, 2009 Aug 26; 252(2). PMID: 19703879
Breast MR imaging during or soon after radiation therapy.
Nuschin Morakkabati, Claudia C Leutner, +2 authors, Christiane Katharina Kuhl.
Radiology, 2003 Nov 01; 229(3). PMID: 14593189
Undiagnosed breast cancer at MR imaging: analysis of causes.
Emmanuelle Bouic Pages, Ingrid Millet, +2 authors, Patrice Taourel.
Radiology, 2012 Apr 24; 264(1). PMID: 22523324
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Sepideh Saadatmand, Madeleine M A Tilanus-Linthorst, +8 authors, Harry J de Koning.
J Natl Cancer Inst, 2013 Aug 14; 105(17). PMID: 23940285
Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.
Noriaki Ohuchi, Akihiko Suzuki, +15 authors, J-START investigator groups.
Lancet, 2015 Nov 09; 387(10016). PMID: 26547101
Highly Cited.
Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, +6 authors, Thomas H Helbich.
J Clin Oncol, 2015 Feb 26; 33(10). PMID: 25713430    Free PMC article.
Highly Cited.
Patterns of breast magnetic resonance imaging use in community practice.
Karen J Wernli, Wendy B DeMartini, +8 authors, Breast Cancer Surveillance Consortium.
JAMA Intern Med, 2013 Nov 20; 174(1). PMID: 24247555    Free PMC article.
Screening Breast MRI in Women with a Personal History of Breast Cancer.
Michelle Tsang Mui Chung, Ana P Lourenco, Martha B Mainiero.
Breast J, 2015 Dec 20; 22(2). PMID: 26684342
Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
Elisa Rush Port, Anna Park, +2 authors, Leslie L Montgomery.
Ann Surg Oncol, 2007 Jan 09; 14(3). PMID: 17206485
Screening breast MR imaging in women with a history of lobular carcinoma in situ.
Janice S Sung, Sharp F Malak, +3 authors, Elizabeth A Morris.
Radiology, 2011 Sep 09; 261(2). PMID: 21900617
Is there a role for routine screening MRI in women with LCIS?
Tari A King, Shirin Muhsen, +6 authors, Monica Morrow.
Breast Cancer Res Treat, 2013 Oct 22; 142(2). PMID: 24141896    Free PMC article.
The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening.
László Tabár, Peter B Dean, +11 authors, Stephen W Duffy.
Cancer, 2018 Nov 10; 125(4). PMID: 30411328    Free PMC article.
Breast cancers detected by breast MRI screening and ultrasound in asymptomatic Asian women: 8 years of experience in Taiwan.
Yu-Chen Cheng, Nai-Yuan Wu, +7 authors, Hui-Cheng Cheng.
Oncology, 2012 Feb 14; 82(2). PMID: 22328009
Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
Nariya Cho, Wonshik Han, +16 authors, Woo Kyung Moon.
JAMA Oncol, 2017 Jun 28; 3(11). PMID: 28655029    Free PMC article.
A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging.
Ritse M Mann, Roel D Mus, +3 authors, Bram Platel.
Invest Radiol, 2014 Apr 03; 49(9). PMID: 24691143
Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery.
Bo Hwa Choi, Nami Choi, +3 authors, Hae Kyoung Jung.
Breast Cancer Res Treat, 2017 Oct 17; 167(2). PMID: 29030785
Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Muriel A Adank, Senno Verhoef, +9 authors, Hanne Meijers-Heijboer.
Eur J Cancer, 2013 Feb 19; 49(8). PMID: 23415889
Pathophysiologic basis of contrast enhancement in breast tumors.
M V Knopp, E Weiss, +8 authors, G van Kaick.
J Magn Reson Imaging, 1999 Oct 03; 10(3). PMID: 10508285
Multireader Study on the Diagnostic Accuracy of Ultrafast Breast Magnetic Resonance Imaging for Breast Cancer Screening.
Jan C M van Zelst, Suzan Vreemann, +11 authors, Ritse M Mann.
Invest Radiol, 2018 Jun 27; 53(10). PMID: 29944483
Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, +19 authors, Harry J de Koning.
Cancer Epidemiol Biomarkers Prev, 2012 Jun 30; 21(9). PMID: 22744338
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, +3 authors, Donald Plewes.
Ann Intern Med, 2008 May 07; 148(9). PMID: 18458280
Highly Cited. Systematic Review.
Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.
Elisabeth Chéreau, Catherine Uzan, +10 authors, Suzette Delaloge.
Clin Breast Cancer, 2010 Mar 20; 10(2). PMID: 20299317
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, +16 authors, Magnetic Resonance Imaging Screening Study Group.
N Engl J Med, 2004 Jul 30; 351(5). PMID: 15282350
Highly Cited.
Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Anna M Chiarelli, Maegan V Prummel, +8 authors, Linda Rabeneck.
J Clin Oncol, 2014 Jun 18; 32(21). PMID: 24934793
The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Johanna O P Wanders, Katharina Holland, +4 authors, Carla H van Gils.
Breast Cancer Res, 2017 Jun 07; 19(1). PMID: 28583146    Free PMC article.
Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions.
Andreas Stadlbauer, Reinhard Bernt, +5 authors, Erich Salomonowitz.
Eur Radiol, 2009 May 06; 19(10). PMID: 19415286
Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer.
Tomasz Huzarski, Barbara Górecka-Szyld, +17 authors, Polish Hereditary Breast Cancer Study Group.
Hered Cancer Clin Pract, 2017 Mar 08; 15. PMID: 28265306    Free PMC article.
Assessment of tumor morphology on diffusion-weighted (DWI) breast MRI: Diagnostic value of reduced field of view DWI.
Maarten W Barentsz, Valentina Taviani, +6 authors, Bruce L Daniel.
J Magn Reson Imaging, 2015 Apr 29; 42(6). PMID: 25914178    Free PMC article.
MRI breast screening in high-risk women: cancer detection and survival analysis.
D Gareth Evans, Evans D Gareth, +19 authors, Duffy Stephen.
Breast Cancer Res Treat, 2014 Apr 02; 145(3). PMID: 24687378
Differences in mammographic density between Asian and Caucasian populations: a comparative analysis.
Nadia Rajaram, Shivaani Mariapun, +9 authors, Soo Hwang Teo.
Breast Cancer Res Treat, 2016 Nov 20; 161(2). PMID: 27864652
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, +5 authors, Hans H Schild.
J Clin Oncol, 2005 Nov 19; 23(33). PMID: 16293877
Highly Cited.
Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.
M J Stoutjesdijk, C Boetes, +8 authors, J O Barentsz.
J Natl Cancer Inst, 2001 Jul 19; 93(14). PMID: 11459871
Personal History of Premenopausal Breast Cancer as a Risk Factor for Referral to Screening Breast MRI.
Stamatia Destounis, Andrea Arieno, Renee Morgan.
Acad Radiol, 2016 Jan 18; 23(3). PMID: 26774742
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Christiane K Kuhl, Kevin Strobel, +3 authors, Simone Schrading.
Radiology, 2017 Feb 22; 283(2). PMID: 28221097
Highly Cited.
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Sylvia K Plevritis, Allison W Kurian, +4 authors, Alan M Garber.
JAMA, 2006 May 25; 295(20). PMID: 16720823
Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Suzan Vreemann, Albert Gubern-Mérida, +5 authors, Ritse M Mann.
Radiology, 2017 Oct 19; 286(2). PMID: 29040037
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer.
M Kriege, C T M Brekelmans, +17 authors, J G M Klijn.
Breast Cancer Res Treat, 2006 Oct 20; 102(3). PMID: 17051427
Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, +45 authors, Marc Tischkowitz.
N Engl J Med, 2014 Aug 08; 371(6). PMID: 25099575    Free PMC article.
Highly Cited.
Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Susan G Moore, Pareen J Shenoy, +2 authors, Christopher R Flowers.
BMC Health Serv Res, 2009 Jan 16; 9. PMID: 19144138    Free PMC article.
Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.
Natasha K Stout, Larissa Nekhlyudov, +6 authors, Suzanne W Fletcher.
JAMA Intern Med, 2013 Nov 20; 174(1). PMID: 24247482    Free PMC article.
The frequency of missed breast cancers in women participating in a high-risk MRI screening program.
S Vreemann, A Gubern-Merida, +4 authors, R M Mann.
Breast Cancer Res Treat, 2018 Feb 01; 169(2). PMID: 29383629    Free PMC article.
The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
C Robertson, S K Arcot Ragupathy, +18 authors, F J Gilbert.
Health Technol Assess, 2011 Sep 29; 15(34). PMID: 21951942    Free PMC article.
Systematic Review.
Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Pål Møller, Astrid Stormorken, +7 authors, Lovise Mæhle.
Breast Cancer Res Treat, 2013 Apr 26; 139(1). PMID: 23615785
Short first-pass MRI of the breast.
Uwe Fischer, Annette Korthauer, +3 authors, Katharina Marten-Engelke.
Acta Radiol, 2012 Feb 16; 53(3). PMID: 22334872
Review.
MR imaging of the breast: comparison with mammography and ultrasound.
S H Heywang, G Fenzl, +4 authors, R Bassermann.
J Comput Assist Tomogr, 1986 Jul 01; 10(4). PMID: 3016044
Abbreviated MRI Protocols for Detecting Breast Cancer in Women with Dense Breasts.
Shuang-Qing Chen, Min Huang, +2 authors, Chuan-Xiao Xu.
Korean J Radiol, 2017 May 02; 18(3). PMID: 28458599    Free PMC article.
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.
Reka Pataky, Linlea Armstrong, +6 authors, Stuart Peacock.
BMC Cancer, 2013 Jul 11; 13. PMID: 23837641    Free PMC article.
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, +15 authors, Jill S Dolinsky.
JAMA Oncol, 2017 Apr 19; 3(9). PMID: 28418444    Free PMC article.
Highly Cited.
Digital mammography screening: sensitivity of the programme dependent on breast density.
Stefanie Weigel, W Heindel, +2 authors, O Heidinger.
Eur Radiol, 2016 Nov 09; 27(7). PMID: 27822617
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, +13 authors, American Cancer Society Breast Cancer Advisory Group.
CA Cancer J Clin, 2007 Mar 30; 57(2). PMID: 17392385
Highly Cited.
Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions.
Pascal A T Baltzer, Matthias Benndorf, +3 authors, Werner A Kaiser.
Eur Radiol, 2009 Nov 26; 20(5). PMID: 19936758
Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.
Kathleen R Brandt, Christopher G Scott, +12 authors, Celine M Vachon.
Radiology, 2015 Dec 24; 279(3). PMID: 26694052    Free PMC article.
Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Ellen Warner, Petrina A Causer, +7 authors, Donald B Plewes.
Breast J, 2011 Jan 22; 17(1). PMID: 21251121
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, +13 authors, Nehmat Houssami.
Br J Cancer, 2016 Feb 26; 114(6). PMID: 26908327    Free PMC article.
Simultaneous multi-slice readout-segmented echo planar imaging for accelerated diffusion-weighted imaging of the breast.
Lukas Filli, Soleen Ghafoor, +6 authors, Andreas Boss.
Eur J Radiol, 2015 Nov 09; 85(1). PMID: 26547123
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, +26 authors, High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study.
Invest Radiol, 2010 Dec 09; 46(2). PMID: 21139507
Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs.
Sebastian Bickelhaupt, Frederik B Laun, +5 authors, Heinz-Peter Schlemmer.
Radiology, 2015 Sep 30; 278(3). PMID: 26418516
Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
Jan C M van Zelst, Roel D M Mus, +7 authors, Ritse M Mann.
Radiology, 2017 Jun 14; 285(2). PMID: 28609204
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
Charu Taneja, John Edelsberg, +3 authors, Jeffrey Weinreb.
J Am Coll Radiol, 2009 Mar 03; 6(3). PMID: 19248993
Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors.
Chana Weinstock, Cristina Campassi, +6 authors, Katherine H R Tkaczuk.
Springerplus, 2015 Sep 01; 4. PMID: 26322264    Free PMC article.
Imaging Surveillance After Primary Breast Cancer Treatment.
Diana L Lam, Nehmat Houssami, Janie M Lee.
AJR Am J Roentgenol, 2017 Jan 12; 208(3). PMID: 28075622    Free PMC article.
Review.
Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
Janie M Lee, Pamela M McMahon, +5 authors, G Scott Gazelle.
Radiology, 2010 Feb 24; 254(3). PMID: 20177093    Free PMC article.
Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.
Inge-Marie Obdeijn, Eveline A M Heijnsdijk, +2 authors, Harry J de Koning.
Eur J Cancer, 2016 Jun 19; 63. PMID: 27318001
Early detection of breast cancer: overview of the evidence on computer-aided detection in mammography screening.
N Houssami, R Given-Wilson, S Ciatto.
J Med Imaging Radiat Oncol, 2009 Jun 17; 53(2). PMID: 19527363
Review.
Earlier detection of breast cancer by surveillance of women at familial risk.
M M Tilanus-Linthorst, C C Bartels, A I Obdeijn, M Oudkerk.
Eur J Cancer, 2000 Mar 16; 36(4). PMID: 10717529
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, +11 authors, Steven A Narod.
J Clin Oncol, 2011 Mar 30; 29(13). PMID: 21444874    Free PMC article.
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
Christiane K Kuhl, Simone Schrading, +5 authors, Hans H Schild.
Lancet, 2007 Aug 19; 370(9586). PMID: 17693177
Highly Cited.
Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
Glen Lo, Anabel M Scaranelo, +5 authors, Pavel Crystal.
Radiology, 2017 Jun 07; 285(1). PMID: 28586291
Study of the reduced field-of-view diffusion-weighted imaging of the breast.
Haibo Dong, Yadi Li, +2 authors, Bin Hu.
Clin Breast Cancer, 2014 Jan 28; 14(4). PMID: 24462803
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, +10 authors, Steven A Narod.
JAMA, 2004 Sep 16; 292(11). PMID: 15367553
Highly Cited.
Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.
Eric T Rosenthal, Brent Evans, +4 authors, Susan Manley.
J Am Coll Radiol, 2016 Dec 25; 14(4). PMID: 28011157
Utility of surveillance MRI in women with a personal history of breast cancer.
Audree Tadros, Brittany Arditi, +3 authors, Hank Schmidt.
Clin Imaging, 2017 Jul 13; 46. PMID: 28700966
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Inge-Marie Obdeijn, Gonneke A O Winter-Warnars, +3 authors, Madeleine M A Tilanus-Linthorst.
Breast Cancer Res Treat, 2014 Feb 26; 144(3). PMID: 24567197
Breast MRI: guidelines from the European Society of Breast Imaging.
R M Mann, C K Kuhl, K Kinkel, C Boetes.
Eur Radiol, 2008 Apr 05; 18(7). PMID: 18389253    Free PMC article.
Highly Cited.
Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment.
Hiroyuki Abe, Naoko Mori, +4 authors, Gregory S Karczmar.
AJR Am J Roentgenol, 2016 Oct 22; 207(5). PMID: 27532897    Free PMC article.
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer.
N Engl J Med, 2016 Oct 13; 375(15). PMID: 27732805
Highly Cited.
Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.
Randy Miles, Fei Wan, +12 authors, Christoph I Lee.
J Womens Health (Larchmt), 2018 Jan 18; 27(6). PMID: 29341851    Free PMC article.
Breast MR imaging screening in women with a history of breast conservation therapy.
Hye Mi Gweon, Nariya Cho, +4 authors, Woo Kyung Moon.
Radiology, 2014 Mar 19; 272(2). PMID: 24635678
Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study.
Anand K Narayan, Kala Visvanathan, Susan C Harvey.
Breast Cancer Res Treat, 2016 Jul 23; 158(3). PMID: 27444927
Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, +16 authors, ACRIN 6666 Investigators.
JAMA, 2012 Apr 05; 307(13). PMID: 22474203    Free PMC article.
Highly Cited.
Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Lauren C Friedlander, Susan Orel Roth, Sara C Gavenonis.
Radiology, 2011 Sep 09; 261(2). PMID: 21900618
MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.
Marleen J Emaus, Marije F Bakker, +15 authors, Carla H van Gils.
Radiology, 2015 Jun 26; 277(2). PMID: 26110667
Premalignant conditions and markers of elevated risk in the breast and their management.
D L Page, W D Dupont.
Surg Clin North Am, 1990 Aug 01; 70(4). PMID: 2371647
Screening Breast MRI Outcomes in Routine Clinical Practice: Comparison to BI-RADS Benchmarks.
Roberta M Strigel, Jennifer Rollenhagen, +5 authors, Wendy B DeMartini.
Acad Radiol, 2016 Dec 18; 24(4). PMID: 27986508    Free PMC article.
Dechelation (Transmetalation): Consequences and Safety Concerns With the Linear Gadolinium-Based Contrast Agents, In View of Recent Health Care Rulings by the EMA (Europe), FDA (United States), and PMDA (Japan).
Val M Runge.
Invest Radiol, 2018 Aug 22; 53(10). PMID: 30130320
Review.
Performance Benchmarks for Screening Breast MR Imaging in Community Practice.
Janie M Lee, Laura Ichikawa, +9 authors, Constance D Lehman.
Radiology, 2017 Jun 06; 285(1). PMID: 28582633    Free PMC article.
Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
Karla Kerlikowske, Christopher G Scott, +11 authors, Celine M Vachon.
Ann Intern Med, 2018 May 02; 168(11). PMID: 29710124    Free PMC article.
Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI.
David V Schacht, Ken Yamaguchi, +3 authors, Hiroyuki Abe.
AJR Am J Roentgenol, 2014 Jan 24; 202(2). PMID: 24450667
Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
Christiane K Kuhl, Annika Keulers, +3 authors, Simone Schrading.
Breast Cancer Res, 2018 Feb 11; 20(1). PMID: 29426360    Free PMC article.
Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
C K Kuhl, R K Schmutzler, +7 authors, H H Schild.
Radiology, 2001 Feb 07; 215(1). PMID: 10751498
Readout-segmented echo-planar imaging improves the diagnostic performance of diffusion-weighted MR breast examinations at 3.0 T.
Wolfgang Bogner, Katja Pinker-Domenig, +5 authors, Stephan Gruber.
Radiology, 2012 Mar 23; 263(1). PMID: 22438442
Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study.
Rubina M Trimboli, Nicola Verardi, +2 authors, Francesco Sardanelli.
AJR Am J Roentgenol, 2014 Aug 26; 203(3). PMID: 25148175
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.
Franca Podo, Filippo Santoro, +14 authors, Francesco Sardanelli.
Clin Cancer Res, 2015 Oct 28; 22(4). PMID: 26503945
Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.
Ken Yamaguchi, David Schacht, +4 authors, Hiroyuki Abe.
AJR Am J Roentgenol, 2013 Oct 24; 201(5). PMID: 24147491
Screening MRI in Women With a Personal History of Breast Cancer.
Constance D Lehman, Janie M Lee, +6 authors, Savannah C Partridge.
J Natl Cancer Inst, 2016 Jan 09; 108(3). PMID: 26744477
The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Suzan Vreemann, Jan C M van Zelst, +5 authors, Ritse M Mann.
Breast Cancer Res, 2018 Aug 05; 20(1). PMID: 30075794    Free PMC article.
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, +10 authors, Hans H Schild.
J Clin Oncol, 2010 Feb 24; 28(9). PMID: 20177029
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Julia Krammer, Katja Pinker-Domenig, +5 authors, Maxine S Jochelson.
Breast Cancer Res Treat, 2017 Mar 28; 163(3). PMID: 28343309    Free PMC article.
Angiogenesis in cancer and other diseases.
P Carmeliet, R K Jain.
Nature, 2000 Sep 23; 407(6801). PMID: 11001068
Highly Cited. Review.
Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience.
Leisha Elmore, Julie A Margenthaler.
Ann Surg Oncol, 2010 Oct 01; 17 Suppl 3. PMID: 20853044
Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers.
Kristin Bosse, Monika Graeser, +3 authors, Kerstin Rhiem.
Arch Gynecol Obstet, 2013 Sep 21; 289(3). PMID: 24045978
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
I Griebsch, J Brown, +20 authors, UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group.
Br J Cancer, 2006 Oct 04; 95(7). PMID: 17016484    Free PMC article.
Screening Breast MRI in Patients Previously Treated for Breast Cancer: Diagnostic Yield for Cancer and Abnormal Interpretation Rate.
Catherine S Giess, Patricia S Poole, +2 authors, Robyn L Birdwell.
Acad Radiol, 2015 Jul 06; 22(11). PMID: 26142951
Application of Abbreviated Protocol of Magnetic Resonance Imaging for Breast Cancer Screening in Dense Breast Tissue.
Shuang-Qing Chen, Min Huang, +2 authors, Chuan-Xiao Xu.
Acad Radiol, 2016 Dec 06; 24(3). PMID: 27916594
Five-year risk of interval-invasive second breast cancer.
Janie M Lee, Diana S M Buist, +6 authors, Rebecca A Hubbard.
J Natl Cancer Inst, 2015 Apr 24; 107(7). PMID: 25904721    Free PMC article.
Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
Tari A King, Melissa Pilewskie, +13 authors, Monica Morrow.
J Clin Oncol, 2015 Sep 16; 33(33). PMID: 26371145    Free PMC article.
MRM promises earlier breast cancer diagnosis.
W A Kaiser.
Diagn Imaging (San Franc), 1992 Aug 06; 14(9). PMID: 10150963
Review.
The benefits and harms of breast cancer screening: an independent review.
Independent UK Panel on Breast Cancer Screening.
Lancet, 2012 Nov 03; 380(9855). PMID: 23117178
Highly Cited. Review.
Breast cancer screening in average-risk women: towards personalized screening.
Almir Gv Bitencourt, Carolina Rossi Saccarelli, Christiane Kuhl, Elizabeth A Morris.
Br J Radiol, 2019 Sep 21; 92(1103). PMID: 31538501    Free PMC article.
Challenges associated with limited-resources cancer care facility: Bilateral breast myeloid sarcoma as an example.
Najmaddin Khoshnaw, Ahmed K Yassin, +2 authors, Layth Mula-Hussain.
Clin Case Rep, 2019 Dec 04; 7(11). PMID: 31788245    Free PMC article.
The emerging role of contrast-enhanced mammography.
Andrea Cozzi, Simone Schiaffino, Francesco Sardanelli.
Quant Imaging Med Surg, 2020 Jan 14; 9(12). PMID: 31929976    Free PMC article.
Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer.
Min Sun Bae, Janice S Sung, +3 authors, Elizabeth A Morris.
J Breast Imaging, 2020 Feb 15; 2(1). PMID: 32055796    Free PMC article.
Machine learning in breast MRI.
Beatriu Reig, Laura Heacock, Krzysztof J Geras, Linda Moy.
J Magn Reson Imaging, 2019 Jul 06; 52(4). PMID: 31276247    Free PMC article.
Review.
Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging.
Vishwa S Parekh, Michael A Jacobs.
Breast Cancer Res Treat, 2020 Feb 06; 180(2). PMID: 32020435    Free PMC article.
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
Inge-Marie Obdeijn, Ritse M Mann, +6 authors, Maartje J Hooning.
Breast Cancer Res Treat, 2020 Apr 26; 181(3). PMID: 32333294    Free PMC article.
A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer.
Wanqing Xiang, Haiying Rao, Liyu Zhou.
Thorac Cancer, 2020 Apr 02; 11(6). PMID: 32233072    Free PMC article.
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Ruxandra Iulia Milos, Francesca Pipan, +5 authors, Pascal A T Baltzer.
Eur Radiol, 2020 Jun 07; 30(11). PMID: 32504098    Free PMC article.
Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay.
Michael A Jacobs, Christopher B Umbricht, +5 authors, Antonio C Wolff.
Cancers (Basel), 2020 Oct 01; 12(10). PMID: 32992569    Free PMC article.
Regulation of Canonical Oncogenic Signaling Pathways in Cancer via DNA Methylation.
Jennifer Lu, Premila Wilfred, Darren Korbie, Matt Trau.
Cancers (Basel), 2020 Nov 05; 12(11). PMID: 33143142    Free PMC article.
Diagnosis of Benign and Malignant Breast Lesions on DCE-MRI by Using Radiomics and Deep Learning With Consideration of Peritumor Tissue.
Jiejie Zhou, Yang Zhang, +9 authors, Min-Ying Su.
J Magn Reson Imaging, 2019 Nov 02; 51(3). PMID: 31675151    Free PMC article.
Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
Isaac Daimiel Naranjo, Roberto Lo Gullo, +7 authors, Katja Pinker-Domenig.
Eur Radiol, 2020 Aug 12; 31(1). PMID: 32780207    Free PMC article.
Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
Matthias F Froelich, Clemens G Kaiser.
Eur Radiol, 2020 Aug 29; 31(2). PMID: 32856166    Free PMC article.
[Artificial intelligence in breast imaging : Areas of application from a clinical perspective].
Pascal A T Baltzer.
Radiologe, 2021 Jan 29; 61(2). PMID: 33507318    Free PMC article.
Review.
Lobular Breast Cancer: A Review.
Natalie Wilson, Alastair Ironside, Anna Diana, Olga Oikonomidou.
Front Oncol, 2021 Feb 02; 10. PMID: 33520704    Free PMC article.
Review.
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk.
H Amarens Geuzinge, Eveline A M Heijnsdijk, +3 authors, FaMRIsc study group.
Breast, 2021 Jan 31; 56. PMID: 33515770    Free PMC article.